Putnam Investments’s Amicus Therapeutics FOLD Stock Holding History

Putnam Investments’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-207,628	Closed	-$2.59M	–	906
2019 Q2	$2.59M	Buy	207,628 +136	+0.1%	+$1.73K	0.01%	687
2019 Q1	$2.82M	Hold	207,492	–	–	0.01%	641
2018 Q4	$1.99M	Hold	207,492	–	–	0.01%	642
2018 Q3	$2.51M	Buy	207,492 +122,614	+144%	+$1.71M	0.01%	724
2018 Q2	$1.32M	Sell	84,878 -1,452	-2%	-$21.9K	﹤0.01%	810
2018 Q1	$1.3M	Buy	+86,330	New	+$1.31M	﹤0.01%	813
2016 Q1	–	Sell	-727,200	Closed	-$7.05M	–	1422
2015 Q4	$7.05M	Hold	727,200	–	–	0.02%	557
2015 Q3	$10.2M	Hold	727,200	–	–	0.02%	448
2015 Q2	$10.3M	Hold	727,200	–	–	0.02%	468
2015 Q1	$7.91M	Hold	727,200	–	–	0.02%	602
2014 Q4	$6.05M	Buy	727,200 +275,000	+61%	+$1.89M	0.01%	708
2014 Q3	$2.69M	Hold	452,200	–	–	0.01%	951
2014 Q2	$1.51M	Hold	452,200	–	–	﹤0.01%	1104
2014 Q1	$936K	Buy	452,200 +2,200	+0.5%	+$5.5K	﹤0.01%	1215
2013 Q4	$1.06M	Hold	450,000	–	–	﹤0.01%	1187
2013 Q3	$1.04M	Hold	450,000	–	–	﹤0.01%	1207
2013 Q2	$1.05M	Buy	+450,000	New	+$1.38M	﹤0.01%	1205

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Putnam Investments's FOLD Position: Q3 2019 in Review

Putnam Investments sold out of Amicus Therapeutics (FOLD) in Q3 2019, closing a stake of 207,628 shares — an estimated $2.59M sold.

Putnam Investments first reported a position in FOLD in Q2 2013 and held it in 17 quarters. The position peaked at $10.3M in Q2 2015. 205 funds tracked by Wall St. Rank hold FOLD as of Q3 2019.

Putnam Investments reported no remaining Amicus Therapeutics position as of Q3 2019 after selling out during the quarter.
Putnam Investments sold 207,628 Amicus Therapeutics shares in Q3 2019, an estimated $2.59M.
Putnam Investments first reported a position in Amicus Therapeutics in Q2 2013 and held it in 17 quarters.
Putnam Investments's Amicus Therapeutics position peaked at $10.3M in Q2 2015.
205 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2019.

Based on Putnam Investments's 13F filing for Q3 2019, filed 14 Nov 2019.